Tara Byrne has experience in all aspects of complex patent litigation in technologies within the pharmaceutical, chemical and biological arts. She has represented leaders in these technological fields, including Bristol-Myers Squibb, AstraZeneca, Novartis, Sanofi, LEO Pharma, Adams Respiratory Therapeutics and Reckitt Benckiser in litigation involving pharmaceutical compounds and compositions. Ms. Byrne has extensive experience in litigating ANDA cases brought under the Hatch-Waxman Act. Tara also has experience representing clients in litigation brought by non-practicing entities (NPEs) and litigating breach of contract and misappropriation of trade secret matters. She also has experience in counseling clients on licensing and other agreements.
Tara is also a licensed Professional Engineer in the State of New York and the State of Vermont.
Tara is Chair of the firm’s Diversity Committee and Chair of the Women’s Initiative Program.
Adams Respiratory Therapeutics, Inc et al. v. Perrigo Company et al.
Fed. Cir. (2010)
Obtained a favorable ruling from the U.S. Court of Appeals for the Federal Circuit in litigation involving a patent covering Reckitt Benckiser’s very successful and popular over-the-counter drug product Mucinex®.